NL-OMON20139
Completed
Not Applicable
Remission induction in early rheumatoid arthritis.
/A0 sites200 target enrollmentTBD
ConditionsObservational study.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Observational study.
- Sponsor
- /A
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. RA according to ACR1987 criteria;
- •2\. diagnosis RA \<3 months;
- •3\. age \>18;
Exclusion Criteria
- •Pregnancy/pregnancy wish.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Remission Induction in Very Early Rheumatoid Arthritis (RIVERA):a comparison of etanercept plus methotrexate plus steroid with standard therapy - RIVERAEUCTR2006-001428-38-GBniversity Hospitals Birmingham NHS Foundation Trust20
Completed
Not Applicable
Remission Induction in Very Early Rheumatoid Arthritis: a comparison of etanercept plus methotrexate plus steroid with standard therapyISRCTN49682259Record Provided by the NHSTCT Register - 2007 Update - Department of Health20
Not yet recruiting
Phase 4
Remission Induction of Very Early Rheumatoid Arthritis with Methotrexate and Etanerceptrheumatoid arthritisJPRN-C000000452Johoku Biological Summit50
Unknown
Phase 4
Remission Induction in Very Early Rheumatoid ArthritisRheumatoid ArthritisNCT00523692University Hospital Birmingham20
Active, not recruiting
Not Applicable
Induction of remission in RA patients at low disease activity by additional Infliximab-therapyPatients with a diagnose of rheumatoid arthritis according to ACR-criteria at least 1 year (max. 10 years) prior to start of therapy with active disease: DAS 28 between 2,8 and 3,5 and a change in DAS 28 score <0.6 during the last 6 weeks before inclusion.EUCTR2005-004530-40-ATAESCA Pharma Ges.m.b.H160